• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal

The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • expand To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
    Study Id
    D961HL00001
    Disease
    gastroesophageal reflux disease
    Drug Name
    Nexium
    Study Name
    D961HL00001
    Recruiting Status
    Closed
    Report
    Jun 6, 2012
    • D961HL00001.pdf (218 KB)
  • expand A Multicenter, Randomized, Open-label Phase IV Study Exploring Symptom Control Rate in Co-diagnosed NERD and Chronic Gastritis Patients Treated With 8 Weeks Esomeprazole Treatment Regimen and 2 Weeks Esomeprazole Treatment Regimen
    Study Id
    D9612L00127
    Disease
    gastroesophageal reflux disease
    Drug Name
    Nexium
    Study Name
    D9612L00127
    Recruiting Status
    Closed
    Report
    May 28, 2012
    • D9612L00127.pdf (633 KB)
  • expand An open-label, randomized, 4-treatment, 3-period, crossover interaction study, evaluating the effect of esomeprazole 40 mg, omeprazole 80 mg or lansoprazole 60 mg on the pharmacodynamics and the pharmacokinetics of clopidogrel in healthy volunteers
    Study Id
    D9612C00034
    Disease
    pharmacodynamics
    Drug Name
    Nexium
    Study Name
    D9612C00034
    Recruiting Status
    Closed
    Report
    May 21, 2012
    • D9612C00034.pdf (206 KB)
  • expand China Survey of Peptic Ulcer Bleeding (PUB)
    Study Id
    NIS-GCN-DUM-2010/1
    Disease
    peptic ulcer
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GCN-DUM-2010/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Mar 23, 2012
    • NIS-GCN-DUM-2010-1.pdf (560 KB)
  • expand A cross-sectional study on the prevalence and extraesophageal symptoms of GERD in patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece.
    Study Id
    NIS-GGR-DUM-2010/1
    Disease
    gastroesophageal reflux disease
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GGR-DUM-2010/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Feb 17, 2012
    • NIS-GGR-DUM-2010-1.pdf (325 KB)
  • expand Prevalence of GERD in Patients with upperGITsymptoms in Thailand
    Study Id
    NIS-GTH-NEX-2009/1
    Disease
    acid reflux
    Drug Name
    Nexium
    Study Name
    NIS-GTH-NEX-2009/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Sep 22, 2011
    • NIS-GTH-NEX-2009/1.pdf (94 KB)
  • expand A multicentre, double-blind, randomised, parallel-group, Phase II study to assess efficacy and safety of D9421-C 9 mg, and 15 mg versus in patients with active Crohn's Disease in Japan
    Study Id
    D9421C00002
    Disease
    Crohn's disease
    Drug Name
    Entocort
    Study Name
    D9421C00002
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jan 18, 1971
    • D9421C00002.pdf (83 KB)
  • expand A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers
    Study Id
    D3830C00001
    Disease
    reflux inhibitor
    Drug Name
    AZD2516
    Study Name
    D3830C00001
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Mar 21, 2011
    • D3830C00001.pdf (126 KB)
  • expand A National, Multicentre, Open-label, Non-comparative, Non-interventional Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium
    Study Id
    NIS-GAL-NEX-2010/1
    Disease
    gastric ulcer
    Drug Name
    Nexium
    Study Name
    NIS-GAL-NEX-2010/1
    Recruiting Status
    Closed
    Report
    Oct 7, 2011
    • NIS-GAL-NEX-2010/1.pdf (141 KB)
  • expand A Phase I, Open, Two-way Crossover, Drug-drug Interaction Study Evaluating the Effect of Esomeprazole on the Pharmacodynamics of Acetylsalicylic Acid After 5 Days of Treatment
    Study Id
    D961FC00011
    Drug Name
    Nexium
    Study Name
    D961FC00011
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Feb 2, 2011
    • D961FC00011.pdf (232 KB)
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013